These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16262214)

  • 1. Radical prostatectomy reduced death and progression more than watchful waiting in early prostate cancer.
    Munro AJ
    ACP J Club; 2005; 143(3):57. PubMed ID: 16262214
    [No Abstract]   [Full Text] [Related]  

  • 2. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting.
    Kirby R
    Nat Clin Pract Urol; 2005 Jun; 2(6):298-303. PubMed ID: 16474812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
    Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
    J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic markers under watchful waiting and radical prostatectomy.
    Holmberg L; Bill-Axelson A; Garmo H; Palmgren J; Norlén BJ; Adami HO; Johansson JE;
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):845-55. PubMed ID: 16861118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prostate cancer: radical prostatectomy or watchful waiting.
    Mandhani A
    Natl Med J India; 2005; 18(4):195-6. PubMed ID: 16252550
    [No Abstract]   [Full Text] [Related]  

  • 8. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Walsh PC
    J Urol; 2005 Oct; 174(4 Pt 1):1291-2. PubMed ID: 16145395
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of prostate cancer with indolent biological potential: from watchful waiting to active surveillance].
    Leibovici D; Lindner A; Stay K; Zisman A
    Harefuah; 2006 Oct; 145(10):763-7, 781, 780. PubMed ID: 17111715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACP Journal Club. Radical prostatectomy reduced mortality and disease progression over the long term more than watchful waiting in early prostate cancer.
    Canfield SE
    Ann Intern Med; 2011 Jul; 155(2):JC1-2. PubMed ID: 21768568
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgical and medical treatment for localized prostate cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.
    Pinthus JH; Witkos M; Fleshner NE; Sweet J; Evans A; Jewett MA; Krahn M; Alibhai S; Trachtenberg J
    J Urol; 2006 Sep; 176(3):979-84; discussion 984. PubMed ID: 16890675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy.
    Hammad FT
    Ann N Y Acad Sci; 2008 Sep; 1138():267-77. PubMed ID: 18837906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological features after radical prostatectomy in potential candidates for active monitoring.
    Griffin CR; Yu X; Loeb S; Desireddi VN; Han M; Graif T; Catalona WJ
    J Urol; 2007 Sep; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer.
    Freedland SJ; Kane CJ; Amling CL; Aronson WJ; Presti JC; Terris MK;
    J Urol; 2006 Apr; 175(4):1298-302; discussion 1302-3. PubMed ID: 16515984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
    Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Partin AW
    J Urol; 2006 Oct; 176(4 Pt 1):1404-8. PubMed ID: 16952644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.